FOLH1 and neoplasm: The tumour-to-muscle ratio for inhibitor [68Ga]Ga-P15 was the lowest of all PSMA inhibitors tested, more than 7-fold lower than the gold standard, [68Ga]Ga-PSMA-617 (Fig. 5).